In the preceding paper, we described the isolation and structure elucidation of a series of even-numbered phenol-or pyrocatechol-derived 1 -arylalkane-5-ones. To establish the assigned structures unambiguously and to have larger quantities available for physiological testing, the following compounds were prepared: in the alkylphenol series, 1-(4-hydroxyphenyl)tetradecan-5-one (2a), 1-(4-hydroxyphenyl)hexadecan-5-one (2b), and 1-(4hydroxyphenyl)octadecan-5-one (2c); in the alkylcatechol series, 1 -(3',4-dihydroxyphenyl)decan-5-one (3a; not isolated as a natural compound), 1-(3',4-dihydroxyphenyl)dodecan-5-one (3b), 1-(3',4'-dihydroxyphenyl)tetradecan-5-one (3c), 1-(3',4'-dihydroxyphenyl)hexadecan-5-one (3d), I-(3',4-dihydroxyphenyl)octadecan-5-one (3e), and 1-(3',4-dihydroxyphenyl)icosan-S-one (30 ; in the alkenylphenol series, (2)-1-(4-hydroxyphenyI)octadec-l3en-5-one (4a) and (E)-l-(4-hydroxyphenyl)octadec-13-en-5-one (4b); in the alkenylcatechol series, (E,E)-l-(3',4'-dihydroxypheny1)deca-1,3-dien-S-one (1) and ( Z ) -1-(3',4'-dihydroxyphenyl)octadec-13-en-5-one (5). All compounds proved to be identical with the previously assigned structures. Compound 1 was synthesized by regioselective aldol condensation of heptan-2-one with (E)l-(3',4'-dimethoxyphenyl)prop-2-enal(6d; Scheme I ) , the phenols 2a+ and the catechols 3a-f by addition of the corresponding alkyl Grignard reagent to 5-(4'-methoxypheny1)or 5-(3',4'-dimethoxyphenyl)pentanal(17~ and 18c, resp.; Scheme 4 ) , and the olefins 4a, 4b and 5 from 17c or 18c oia the 9-0 -silyl-protected 13-(4'-methoxyphenyl)-or 13-(3',4'-dimethoxyphenyl)tridecanals (26 and 27, resp.) and Wittig olefination as the key steps (Scheme 5 ) .